Young David
Director, Pres. Research & Development · 8 filings · Latest: Jun 30, 2026
Processa Pharmaceuticals, Inc.
| Ticker | Owner | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total | SEC Filing |
|---|---|---|---|---|---|---|---|---|---|
PCSA | Young David | Director, Pres. Research & Development | Jun 30, 2026 | Purchase | $1.93 | 2,531 | $4.9K | 21,729 | |
PCSA | Young David | Director, Pres. Research & Development | Jun 15, 2026 | Purchase | $2.22 | 2,067 | $4.6K | 19,198 | |
PCSA | Young David | Director, Pres. Research & Development | May 29, 2026 | Purchase | $2.57 | 1,786 | $4.6K | 17,131 | |
PCSA | Young David | Director, Pres. Research & Development | May 15, 2026 | Purchase | $2.97 | 1,545 | $4.6K | 15,345 | |
PCSA | Young David | Director, Pres. Research & Development | Apr 30, 2026 | Purchase | $2.69 | 1,706 | $4.6K | 13,813 | |
PCSA | Young David | Director, Pres. Research & Development | Apr 15, 2026 | Purchase | $2.97 | 1,545 | $4.6K | 12,107 | |
PCSA | Young David | Director, Pres. Research & Development | Mar 31, 2026 | Purchase | $2.54 | 1,810 | $4.6K | 10,562 | |
PCSA | Young David | Director, Pres. Research & Development | Jan 1, 2026 | Option Exercise | $0.00 | 49 | — | 8,752 |